Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Telescope in Chile captures stunning new picture of a cosmic butterfly- Energy agency chief warns of 'black April' for oil supplies
- The most effective method to Amplify Your Opportunity for growth in a Web-based Degree Program
- 5 Superstar Couples That Motivate Relationship Objectives
- Schools to start reopening after Nigeria mass abduction
- Iranian-linked drone attack kills Kurdish couple in northern Iraq
- 'Everyone in this prison has had family killed or shot'
- Former United Launch Alliance CEO Tory Bruno joins competitor Blue Origin for national security projects
- Benin coup thwarted by loyalist troops, president tells nation
